Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Gains from Investment Securities (2017 - 2025)

Historic Gains from Investment Securities for Healthequity (HQY) over the last 12 years, with Q4 2025 value amounting to $844000.0.

  • Healthequity's Gains from Investment Securities fell 9184.23% to $844000.0 in Q4 2025 from the same period last year, while for Oct 2025 it was $9.6 million, marking a year-over-year decrease of 7207.78%. This contributed to the annual value of $26.1 million for FY2025, which is 2625.88% down from last year.
  • As of Q4 2025, Healthequity's Gains from Investment Securities stood at $844000.0, which was down 9184.23% from $6.6 million recorded in Q3 2025.
  • In the past 5 years, Healthequity's Gains from Investment Securities registered a high of $15.1 million during Q3 2023, and its lowest value of -$4.9 million during Q2 2021.
  • For the 5-year period, Healthequity's Gains from Investment Securities averaged around $3.0 million, with its median value being $406000.0 (2022).
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first crashed by 39917.7% in 2021, then skyrocketed by 468415.84% in 2023.
  • Healthequity's Gains from Investment Securities (Quarter) stood at -$381000.0 in 2021, then surged by 153.02% to $202000.0 in 2022, then surged by 4684.16% to $9.7 million in 2023, then increased by 7.06% to $10.3 million in 2024, then crashed by 91.84% to $844000.0 in 2025.
  • Its Gains from Investment Securities was $844000.0 in Q4 2025, compared to $6.6 million in Q3 2025 and -$46000.0 in Q2 2025.